https://www.prnewswire.com/ae/news-releases/seegene-reports-solid-results-in-the-first-quarter-of-2021-with-krw-351-8-billion-815842708.html
/PRNewswire/ -- Seegene Inc. (KQ 096530), a molecular diagnostics company reported its financial results for the first quarter of 2021, with reports showing...
in thefirst quarterseegenereportssolid
https://www.prnewswire.com/ae/news-releases/seegene-unveils-blueprint-for-the-future-of-molecular-diagnostics-including-open-development-platform-at-the-40th-annual-j-p-morgan-healthcare-conference-852176042.html
/PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics (MDx) company, today, unveiled its blueprint for the future during a...
for the futuremolecular diagnosticsseegeneblueprintincluding
https://www.businesswire.com/news/home/20210301005154/en/Seegene-Announces-Submission-to-U.S.-FDA-for-Emergency-Use-Authorization-of-Its-AllplexTM-SARS-CoV-2FluAFluBRSV-Assay
Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of its AllplexTM SARS-CoV-2/FluA/FluB/RSV Assay
to useegeneannouncessubmissionfda